Sercan Aksoy Selected Research

Neoplasms (Cancer)

3/2024	Sonographic Measurements of Rectus Femoris Muscle Thickness Strongly Predict Neutropenia in Cancer Patients Receiving Chemotherapy.
2/2024	Targeting TACC3 induces immunogenic cell death and enhances T-DM1 response in HER2-positive breast cancer.
12/2023	Sarcopenia and anthracycline cardiotoxicity in patients with cancer.
11/2023	Seven-Year Single-Center Experience of the Efficacy and Safety of Ferric Carboxymaltose in Cancer Patients with Iron-Deficiency Anemia.
11/2023	Mean Platelet Volume to Lymphocyte Ratio: A New Biomarker Predicting Response in Patients with Solid Tumors Treated with Nivolumab.
10/2023	Molecularly imprinted electrochemical sensor for the selective and sensitive determination of octreotide in cancer patient plasma sample.
9/2023	Reviving immunogenic cell death upon targeting TACC3 enhances T-DM1 response in HER2-positive breast cancer.
7/2023	The benefit of treatment beyond progression with immune checkpoint inhibitors: a multi-center retrospective cohort study.
4/2023	Impact of adding pertuzumab to trastuzumab plus chemotherapy in neoadjuvant treatment of HER2 positive breast cancer patients: a multicenter real-life HER2PATH study.
1/2023	Immunogenicity of two doses of inactive COVID-19 vaccine and third booster dose mRNA vaccine in patients with cancer receiving active systemic therapy.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Sercan Aksoy Research Topics

Disease

66	Neoplasms (Cancer) 03/2024 - 01/2004
56	Breast Neoplasms (Breast Cancer) 03/2024 - 01/2004
19	Neoplasm Metastasis (Metastasis) 03/2024 - 11/2005
8	Cardiotoxicity 12/2023 - 05/2005
7	Triple Negative Breast Neoplasms 07/2023 - 04/2009
7	Disease Progression 02/2023 - 01/2012
7	Prostatic Neoplasms (Prostate Cancer) 01/2023 - 01/2015
6	Colorectal Neoplasms (Colorectal Cancer) 03/2015 - 01/2013
6	Lymphoma (Lymphomas) 03/2009 - 04/2004
5	Squamous Cell Carcinoma of Head and Neck 03/2024 - 01/2017
5	Infections 01/2021 - 01/2006
5	Carcinoma (Carcinomatosis) 01/2017 - 10/2006
5	Stomach Neoplasms (Stomach Cancer) 02/2016 - 01/2011
4	Acute Kidney Injury (Acute Renal Failure) 03/2024 - 01/2013
4	Nasopharyngeal Carcinoma 05/2023 - 01/2004
4	Osteoporosis 01/2016 - 03/2011
3	Neutropenia 03/2024 - 03/2009
3	Sarcopenia 12/2023 - 01/2023
3	Head and Neck Neoplasms (Head and Neck Cancer) 01/2023 - 06/2021
3	Obesity 01/2016 - 01/2006
3	Adenocarcinoma 01/2014 - 01/2010
3	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2009 - 07/2007
2	Deglutition Disorders (Dysphagia) 03/2024 - 08/2023
2	Stomatitis 03/2024 - 07/2021
2	Anemia 11/2023 - 07/2021
2	Vomiting 01/2023 - 10/2021
2	Fatigue 01/2023 - 07/2021
2	Male Breast Neoplasms (Male Breast Cancer) 12/2022 - 06/2012
2	Hypoalbuminemia 09/2022 - 01/2022
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2022 - 09/2021
2	Rheumatic Diseases (Rheumatism) 01/2021 - 02/2019
2	Hematologic Neoplasms (Hematological Malignancy) 02/2019 - 01/2005
2	Heart Failure 03/2015 - 12/2014
2	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2014 - 08/2006
2	Chronic Hepatitis (Chronic Active Hepatitis) 06/2014 - 05/2008

Drug/Important Bio-Agent (IBA)

15	Hormones (Hormone)IBA 03/2024 - 05/2008
14	Trastuzumab (Herceptin)FDA Link 04/2023 - 01/2012
9	Immune Checkpoint InhibitorsIBA 11/2023 - 03/2020
8	Doxorubicin (Adriamycin)FDA LinkGeneric 02/2015 - 01/2004
7	AnthracyclinesIBA 03/2024 - 10/2014
7	ErbB Receptors (EGF Receptor)IBA 02/2024 - 01/2012
7	Biomarkers (Surrogate Marker)IBA 11/2023 - 03/2015
7	pertuzumabIBA 04/2023 - 01/2012
7	Aromatase InhibitorsIBA 03/2023 - 10/2008
7	Fluorouracil (Carac)FDA LinkGeneric 01/2017 - 03/2005
6	Cisplatin (Platino)FDA LinkGeneric 08/2023 - 01/2004
6	Capecitabine (Xeloda)FDA Link 07/2015 - 03/2005
6	Rituximab (Mabthera)FDA Link 06/2014 - 03/2006
5	Ado-Trastuzumab EmtansineIBA 02/2024 - 04/2013
5	Paclitaxel (Taxol)FDA LinkGeneric 04/2023 - 05/2005
5	Diphosphonates (Bisphosphonates)IBA 01/2013 - 01/2004
4	Immunoconjugates (Immunoconjugate)IBA 02/2024 - 04/2013
4	Estrogen ReceptorsIBA 11/2023 - 02/2011
4	Docetaxel (Taxotere)FDA Link 04/2023 - 09/2014
4	taxaneIBA 07/2021 - 04/2013
4	Zoledronic Acid (Zometa)FDA Link 01/2016 - 01/2008
4	Leucovorin (Folinic Acid)FDA Link 09/2014 - 01/2010
4	Oxaliplatin (Eloxatin)FDA LinkGeneric 09/2014 - 01/2011
4	Ifosfamide FDA LinkGeneric 01/2012 - 01/2004
3	pembrolizumabIBA 03/2024 - 06/2020
3	Fulvestrant (Faslodex)FDA Link 03/2024 - 08/2021
3	palbociclibIBA 03/2024 - 03/2023
3	ribociclibIBA 03/2024 - 03/2023
3	human ERBB2 proteinIBA 12/2023 - 01/2011
3	Tamoxifen FDA LinkGeneric 11/2023 - 01/2004
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 05/2023 - 02/2014
3	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 09/2021 - 01/2014
3	Everolimus FDA Link 07/2021 - 01/2014
3	exemestane (Aromasin)FDA Link 07/2021 - 01/2014
3	abirateroneIBA 01/2021 - 05/2019
3	Lapatinib (GW572016)FDA Link 06/2014 - 04/2013
3	Bevacizumab (Avastin)FDA Link 01/2014 - 01/2011
3	PlatinumIBA 11/2013 - 01/2004
2	Cyclin-Dependent Kinases (cdk Proteins)IBA 02/2024 - 11/2022
2	NivolumabIBA 11/2023 - 09/2021
2	Proteins (Proteins, Gene)FDA Link 05/2023 - 01/2023
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2023 - 05/2019
2	Cyclin-Dependent Kinase 4IBA 12/2022 - 11/2022
2	AlbuminsIBA 01/2022 - 01/2022
2	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 09/2018
2	RNA (Ribonucleic Acid)IBA 01/2020 - 05/2008
2	Abiraterone AcetateIBA 10/2019 - 05/2019
2	TOR Serine-Threonine KinasesIBA 01/2016 - 06/2014
2	Tyrosine Kinase InhibitorsIBA 01/2016 - 06/2014
2	C-Reactive ProteinIBA 03/2015 - 10/2009
2	Cytotoxins (Cytolysins)IBA 02/2015 - 04/2013
2	Phenobarbital (Luminal)FDA Link 01/2015 - 04/2009
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015 - 07/2007

Therapy/Procedure

38	Therapeutics 03/2024 - 01/2005
37	Drug Therapy (Chemotherapy) 03/2024 - 01/2004
14	Radiotherapy 08/2023 - 03/2008
10	Immunotherapy 05/2023 - 01/2016
8	Chemoradiotherapy 03/2024 - 01/2010
5	Neoadjuvant Therapy 07/2023 - 10/2012
4	Castration 01/2023 - 05/2019
2	Drug Tapering 03/2024 - 01/2006
2	Polypharmacy 06/2022 - 04/2021
2	Gastrectomy 02/2016 - 10/2012
2	Duration of Therapy 03/2015 - 12/2014
2	Adjuvant Chemotherapy 10/2014 - 01/2013